Tech Company Financing Transactions
Enveda Biosciences Funding Round
On 12/17/2020, Enveda Biosciences secured $4.9 million in Seed funding from True Ventures, private investors and Village Global.
Transaction Overview
Company Name
Announced On
12/17/2020
Transaction Type
Venture Equity
Amount
$4,900,000
Round
Seed
Investors
True Ventures (Lead Investor) (Rohit Sharma)
private investors (Chris Gibson)
Proceeds Purpose
The seed round will enable Enveda to grow its medicinal plant dataset, enhance its technologies and algorithms to further accelerate natural product drug discovery and advance its lead asset for liver fibrosis through preclinical development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1880 S Flatiron Ct. K
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
At Enveda, we're harnessing the complexity of the natural world to tackle today's biggest healthcare challenges. With the help of breakthrough advancements in knowledge graphs, machine learning, and metabolomics, we're discovering the next generation of small molecules.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Viswa Colluru
Chief Scientific Officer
Sotirios Karathanasis
Chief Technical Officer
Joseph Rokicki
Vice President
David Healey
Vice President
Bryan Norman
VP - Administration
Daniel Wee
VP - Engineering
Chris Diana
VP - Product Management
Hannah Gordon
Browse more venture capital transactions:
Prev: 12/17/2020: Neurogene venture capital transaction
Next: 12/17/2020: Bestow venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs